Lymphoma Research Foundation Funds 28 New Grants Supporting the Next Generation of Lymphoma Scientists
Lymphoma Research Foundation Funds 28 New Grants Supporting the Next Generation of Lymphoma Scientists New…
Lymphoma Research Foundation Funds 28 New Grants Supporting the Next Generation of Lymphoma Scientists New…
Updates from the 2023 American Society of Hematology Annual Meeting The Lymphoma Research Foundation (LRF)…
ASH 2023: Increased Metabolism in High IRF4-Expressing Lymphoma Cells Limits the Availability of Glucose in…
ASH 2023: Durable Responses Observed with Valemetostat Improved Outcomes in Second-Line Treatment of Large B-Cell…
ASH 2023: Durable Responses Observed with Valemetostat Tosylate Treatment in Relapsed/Refractory Peripheral T-Cell Lymphoma Treatment…
ASH 2023: Overall Survival in Mantle Cell Lymphoma Has Improved in the Era of Targeted…
ASH 2023: High Complete Response Rates in High-Risk Relapsed/Refractory Follicular Lymphoma Treated with Loncastuximab Tesirine…
ASH 2023: Total Lifetime Costs of Treating Chronic Lymphocytic Leukemia are High Treatment advances in…
ASH 2023: Barriers Identified to the Use of CAR T-cell Therapy in Non-Hodgkin Lymphoma While…
ASH 2023: MRD Status Predicts Progression-free Survival Outcomes in Follicular Lymphoma The disease course in…